Paul Gaglio
Medical · New York, NYNPI 1013403559
Payments from drug & device makers
Across 14 payments — averaging $131.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Boston Scientific$215
- International Rehabilitative Sciences, Inc$73
- Bioventus LLC$67
- Gilead$26
- Si-bone, Inc.$25
- plus $39 from 2 others
What the payments were for
- Speaking & faculty fees$1,40076%
- Food & beverage$44424%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $1,400 |
| Boston Scientific | 6 | $215 |
| International Rehabilitative Sciences, Inc | 1 | $73 |
| Bioventus LLC | 2 | $67 |
| Gilead | 1 | $26 |
| Si-bone, Inc. | 1 | $25 |
| Curonix LLC | 1 | $23 |
| Vertex | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIFAXAN$1,400
How this compares
$1,844 in reported general payments places this provider in the 75th percentile of 2,395 medical providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 18 | $23,830 |
| Gabapentin | 187 | $1,513 |
| Lidocaine | 17 | $563 |
| Cyclobenzaprine Hcl | 28 | $352 |
| Oxycodone Hcl | 31 | $283 |
| Tizanidine Hcl | 31 | $264 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $263 |
| Duloxetine Hcl | 17 | $225 |
| Pregabalin | 19 | $171 |
| Naproxen | 19 | $138 |
| Meloxicam | 25 | $108 |
| Tramadol Hcl | 25 | $82 |
Paid to pharmacies, not to this prescriber.
Other medical in New York
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Maureen ThyneNew York$109K
- Helen AdamsNew York$87K
- Hailey BrickmanNew York$82K
- Maria BaldoNew York$40K
- Michael QuerijeroNew York$32K
- Meiting LiangNew York$25K
- Karina SodenNew York$23K
- Valentin BonillaNew York$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.